IL15 and neoplasm: An analysis of tumor organoid models complemented with primary immune cells and in vivo experiments in immunocompetent mouse tumor models may be helpful to further investigate the modulation of the tumor immune microenvironment by NKAR_RD-IL15-NK-92 cells and potential exhaustion of the CAR-NK cells in a setting that more closely reflects the clinical situation [55].